Results 51 to 60 of about 3,587 (183)

Short-term vasoactive agent treatment driven by physicians’ preference in acute esophageal variceal bleeding in a tertiary center [PDF]

PeerJ, 2019
Background Vasoactive drugs are frequently used in combination with endoscopic variceal ligation (EVL) in treatment of acute esophageal variceal bleeding (EVB).
Yoen Young Chuah, Ping-I Hsu, Wei-Lun Tsai, Hsien-Chung Yu, Feng-Woei Tsay, Wen-Chi Chen, Kung Hung Lin, Yeong Yeh Lee, Huay-Min Wang   +8 more
doaj   +2 more sources

Vasoactive–Inotropic Score Reduction Rate Is Highly Associated With Prognosis for Critically Ill Patients With Cardiogenic Shock: Insights From the Real‐World Dynamic Data

Cardiovascular Therapeutics, Volume 2026, Issue 1, 2026.
Background In cardiogenic shock (CS), titration of both the choice and dosage of inotropes and vasopressors is crucial. The vasoactive–inotropic score (VIS) quantifies hemodynamic support, while the effect of temporal VIS change on prognosis remains unclear. This study evaluated the association between the vasoactive–inotropic score reduction rate (VRR)
Yi-Le Ning, Tian-Xiang Guan, Xiao-Li Niu, Qian-Qian Ma, Yuan-Na Zhang, Ting-Yu Peng, Li-Xiong Zeng, Hang Li, Hui-Ting Guan, Irfan Ahmad   +9 more
wiley   +1 more source

No Difference in Mortality between Terlipressin and Somatostatin Treatments in Cirrhotic Patients with Esophageal Variceal Bleeding and Renal Functional Impairment

, 2016
Objective To study the differences in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding (EVB) and renal functional impairment (RFI). Methods The National Health Insurance Database, part of
Hung, Tsung-Hsing; Tsai, Chen-Chi; Tseng, Chih-Wei; Tseng, Kuo-Chih; Hsieh, Yu-Hsi; Tsai, Chih-Chun, Chih-Chun Tsai, Yu-Hsi Hsieh, Kuo-Chih Tseng, Tsung-Hsing Hung, Chen-Chi Tsai, Chih-Wei Tseng   +6 more
core   +1 more source

Terlipressin-related Ischaemic Necrosis of the Skin: A Rare Complication [PDF]

, 2019
Terlipressin is used for the treatment of bleeding oesophageal varices and hepatorenal syndrome in patients with cirrhosis. Adverse effects are usually minimal.
Novais, António, Macedo, Sara, Knock, Anna, Cabral, Cátia, Teixeira, Mónica   +4 more
core   +1 more source

Impact of Cirrhosis Etiology and Intensive Care Accessibility on Upper Gastrointestinal Bleeding: A Prospective Observational Study

Canadian Journal of Gastroenterology and Hepatology, Volume 2026, Issue 1, 2026.
Background Upper gastrointestinal bleeding (UGIB) is a significant cause of cirrhosis decompensation; however, there is still controversy on risk factors for poor outcomes. This study aims to explore the impact of additional variables, such as liver disease etiology and intensive care unit (ICU) accessibility, on mortality, rebleeding, and infection ...
Mariana Barros Marcondes, Clara Fantinelli Moreno, Cíntia Mitsue Pereira Suzuki, Maxwell Antonio Garcia Rodrigues, Alecsandro Moreira, Xingshun Qi, Fernando Gomes Romeiro, Srijoni Sengupta   +7 more
wiley   +1 more source

Evaluating the Prognostic Accuracy of New Scores for In‐Hospital Outcomes in Cirrhotic Patients With Esophageal Variceal Bleeding

Canadian Journal of Gastroenterology and Hepatology, Volume 2026, Issue 1, 2026.
Background Esophageal variceal bleeding (EVB) is a serious complication of cirrhosis and a major cause of upper gastrointestinal hemorrhage, carrying substantial risks of mortality and treatment failure. Prognostic scores are essential for guiding management.
Khoa Phuoc Nguyen, Xung Van Nguyen, Nhan Duc Le, Trung Hieu Doan, Srijoni Sengupta   +4 more
wiley   +1 more source

Terlipressin for Hepatorenal Syndrome: Novel Strategies and Future Perspectives

, 2011
Type 1 hepatorenal syndrome (HRS) is a functional renal failure that often occurs in patients with cirrhosis and ascites. Type 1 HRS develops as the consequence of a severe reduction of effective circulating volume due to both extreme splanchnic arterial
P. Angeli, Angeli P.
core   +1 more source

Terlipressin for Hepatorenal Syndrome: A Meta-Analysis of Randomized Trials

, 2009
Background Hepatorenal syndrome (HRS) is a severe complication of end-stage renal disease whose management still constitutes a big challenge. Various approaches have been used for hepatorenal syndrome treatment, including vasoconstrictor therapy ...
Piergiorgio Messa, Messa, Piergiorgio, Fabrizi, Fabrizio, Martin, Paul, Paul Martin, Fabrizio Fabrizi, Dixit, Vivek, Vivek Dixit   +7 more
core   +2 more sources

Terlipressin for septic shock patients: a meta-analysis of randomized controlled study

Journal of Intensive Care, 2019
Background Catecholamines are commonly used in septic shock but face limitations of their hypo-responsiveness and adverse events due to high dose. Terlipressin is a synthetic vasopressin analog with greater selectivity for the V1-receptor.
Yibing Zhu, Huibin Huang, Xiuming Xi, Bin Du   +3 more
doaj   +1 more source

Systematic review: Terlipressin in acute oesophageal variceal haemorrhage

, 2003
Background: Controversy exists surrounding pharmacological therapy in acute variceal bleeding. Methods: To determine the efficacy and safety of terlipressin.
Rockey, DC, Ioannou, GN, G. N. Ioannou, J. Doust, D. C. Rockey, Doust, J   +5 more
core   +1 more source